Experts analyze the unique biomechanical risks for traumatic brain injury in winter sports following high-profile incidents ...

GLP-1 RAs are prescribed to about 20% of potentially eligible adolescents, with increasing odds based on several individual factors.

Current smoking status may be linked to lower risk for Parkinson disease, but health experts aren't sure what drives this association.

The Pan American Health Organization delays a review of US measles elimination status to “simplify and standardize the assessment process.” ...

The growing burden of ALS in the US highlights the need for earlier diagnosis, multidisciplinary care, and expanded access to emerging therapies.

Some states are planning to spend less on HIV medication programs in an attempt to solve budget deficits and federal funding cuts.

A new drug may help treat and eventually eliminate sleeping sickness by improving adherence and accessibility to treatment.

New genetic data shows no meaningful overlap between vitamin B12 status determinants and Parkinson disease outcomes in clinical cohorts.

The CDC will once again review COVID-19 vaccine safety as health experts criticize a potential lack of scientific basis for this move.

A meta-analysis shows GLP-1 RA therapy does not significantly lower vascular dementia events compared with placebo in high-risk patient groups.

Comorbid insomnia and sleep apnea with short sleep duration significantly increases the risk for incident hypertension in a general population.

Based on current trends in cardiovascular health for women, cardiovascular risk and disease are projected to increase through 2050.